AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2021 Issue 4; Section X-New Technology

Chimeric Antigen Receptor T-Cell Immunotherapy

Chimeric Antigen Receptor (CAR) T-cell immunotherapy is a cell-based gene therapy in which immune cells are removed from a patient, armed with new proteins that allow them to recognize cancer, and then reinfused into the patient in large numbers. These cells persist in the body, becoming “living drugs.” Changes have been made to resolve the conflict for the intravenous administration of CAR T-cell therapies, which had been classified to two different tables. The two codes in Table XW0, Anatomical Regions, Introduction, were not product-specific, with Substance value C, Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy. Yescarta® (axicabtagene...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .

Thank you for choosing Find-A-Code, please Sign In to remove ads.